|
Volumn 374, Issue 9696, 2009, Pages 1119-
|
A (prime) boost for HIV vaccine research?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLYCOPROTEIN GP 120;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
PLASMID DNA;
RECOMBINANT VACCINE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMORAL IMMUNE DEFICIENCY;
HUMORAL IMMUNITY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
AIDS VACCINES;
FOLLOW-UP STUDIES;
FORECASTING;
HUMANS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
THAILAND;
UNITED STATES;
|
EID: 70349486912
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(09)61720-7 Document Type: Editorial |
Times cited : (3)
|
References (0)
|